Entries by oslocancer

Can Norway compete internationally on health?

Can Norway take a leading international position within health industry? This was the main question for one of our discussions at Arendalsuka last week. A report released in April this year shows a Norwegian health industry on the rise. However internationally, Norway is still comparatively small even compared to our Nordic neighbors. SEE VIDEO FROM THE MEETING […]

Tim: Pasienten som kommer hjem

Kan digitale løsninger lette hverdagen for pasienter som kommer hjem etter endt behandling? Det ville Oslo Cancer Cluster, sammen med Kreftforeningen og IKT Norge finne ut av på ettermiddagsprogrammet under Arendalsuka onsdag. Arrangement: PASIENTEN KOMMER HJEM – PAKKEFORLØP OG DIGITAL OPPFØLGING Kreftpasienten Tim Daglig leder for Oslo Cancer Cluster og konferansier Ketil Widerberg begynte med […]

Fremtidens kreftbehandling i Arendal

Gikk du glipp av frokostmøtet vårt i Arendal? Her kan du få det med deg likevel! Fremtidens kreftbehandling handler om helsedata, persontilpasset medisin, kreftvaksiner og ambisiøse forskere og pådrivere.  Noen av disse pådriverne kunne du se og høre under vårt frokostmøte i Arendal 15. August 2018. Møteserien “Fremtidens kreftbehandling” er et samarbeid mellom Kreftforeningen, MSD […]

Promising treatment for late stage cancer

MetAction has used targeted gene therapy to give patients with metastatic cancer a treatment method. The future of this work is now in danger. Late stage cancer is still a real challenge for modern medicine. The gene mutations multiply and are difficult to control. However, the research group MetAction, based at the Oslo University Hospital, […]

New report on Norwegian health industry

Will the Norwegian health industry become a so-called growth industry? What kind of position can a Norwegian health industry claim internationally?  These questions are at the core of a new report on the Norwegian health industry, published by Innovation Norway. According to Innovation Norway, health is one of six areas of opportunity for Norwegian export growth. […]

Meet Us at Arendalsuka

In mid-August Oslo Cancer Cluster travel to Arendal to put focus on cancer treatment and innovation. Arendalsuka is a week of political discourse and interaction, and Oslo Cancer Cluster want to highlight several cancer related topics we find important. In total, we are hosting or co-hosting three different events! On Wednesday August the 15th we […]

Ullern Student With a Career in Medicine

Aksel Stien graduated from Ullern Secondary School in 2011. Today he is a physician working on his specialty subjects at Oslo University Hospital. Aksel has always wanted to become a physician and the foundation was already in place at Ullern. He learned things from his deployment at The Norwegian Radium Hospital during his upper secondary […]

Cancer Innovation Pitched to Investors

A full house presented itself when Inven2 pitched 8 of their most promising cancer research projects at Oslo Cancer Cluster Incubator June 12th. In total approximately 60 people gathered inside Oslo Cancer Cluster Innovation Park, and among the participants several experienced investors from other cancer projects. — I’m positively surprised that so many potential and […]

New Chairman at OCC

Øyvind Kongstun Arnesen is appointed new chairman at Oslo Cancer Cluster (OCC). On a recent General Assembly, Oslo Cancer Cluster elected Øyvind Kongstun Arnesen as new chairman after a unanimous vote. He takes over after Henrik Lund who opted not to stand for re-election after four years in the position. Øyvind is currently CEO at […]

AI Speeds Up Pharmaceutical Testing

Oslo Cancer Cluster member Immunitrack has landed investments worth millions. The money will be used to develop a computer program that can predict how the immune system will react to different substances. Already Immunitrack, co-founded by Stephan Thorgrimsen and Sune Justesen, is offering contracted research to the pharmaceutical industry predicting how the immune system react […]